609PTesting cognitive development in weak infants with spinal muscular atrophy: insights and challenges
Bianca Buchignani(University of Pisa), E. Mercuri(Università Cattolica del Sacro Cuore), Roberta Battini(Fondazione Stella Maris), Marika Pane(Università Cattolica del Sacro Cuore), Giulia Stanca(Agostino Gemelli University Polyclinic), Paola Cristofani(Fondazione Stella Maris), Giorgia Coratti, C. Cutrì(Agostino Gemelli University Polyclinic), Rita De Sanctis(Humanitas University)
Cited by 0
Related Papers
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
|The Lancet Neurology|2021|260
Functional changes in Duchenne muscular dystrophy
|Neurology|2011|178
GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findings
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2011|157